Your browser doesn't support javascript.
loading
CDK Inhibition Reverses Acquired 5-Fluorouracil Resistance in Hepatocellular Carcinoma Cells.
Pu, Yiyi; Yan, Dongmei; Tu, Linglan; Cheng, Liyan; Yu, Jie; Li, Zhuduo; Zheng, Xiaoliang; Wang, Xinbao.
Afiliação
  • Pu Y; Department of the Hepato-Biliary-Pancreatic Surgery, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, China.
  • Yan D; School of Bioengineering, Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Tu L; School of Bioengineering, Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Cheng L; School of Bioengineering, Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Yu J; School of Bioengineering, Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Li Z; School of Bioengineering, Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Zheng X; School of Bioengineering, Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Wang X; School of Bioengineering, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Dis Markers ; 2022: 6907057, 2022.
Article em En | MEDLINE | ID: mdl-35308136

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Quinases Ciclina-Dependentes / Resistencia a Medicamentos Antineoplásicos / Fluoruracila / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Dis Markers Assunto da revista: BIOQUIMICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Quinases Ciclina-Dependentes / Resistencia a Medicamentos Antineoplásicos / Fluoruracila / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Dis Markers Assunto da revista: BIOQUIMICA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China